Holen Sie sich die Stockscreener-App
335.69
1.03%
-3.6087
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$339.30
Offen:
$340.56
24-Stunden-Volumen:
824.03K
Relative Volume:
0.32
Marktkapitalisierung:
$181.23B
Einnahmen:
$37.30B
Nettoeinkommen (Verlust:
$7.80B
KGV:
23.35
EPS:
14.3793
Netto-Cashflow:
$8.60B
1W Leistung:
+1.53%
1M Leistung:
-2.53%
6M Leistung:
-2.54%
1J Leistung:
+23.62%
1-Tages-Spanne:
$335.40
$342.49
1-Wochen-Bereich:
$326.80
$343.80
52-Wochen-Spanne:
$267.83
$391.29
Amgen Inc Stock (AMGN) Company Profile
Firmenname
Amgen Inc
Sektor
Telefon
(805)447-1000
Adresse
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN vs LLY, JNJ, ABBV, MRK, AZN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
335.80 | 183.12B | 37.30B | 7.80B | 8.60B | 14.38 |
LLY
Lilly Eli Co
|
1,072.55 | 949.70B | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
230.69 | 564.11B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
212.55 | 381.10B | 62.82B | 3.60B | 19.98B | 2.0274 |
MRK
Merck Co Inc
|
120.23 | 302.33B | 65.51B | 8.93B | 14.12B | 3.5532 |
AZN
Astrazeneca Plc
|
187.27 | 290.06B | 60.48B | 10.40B | 8.05B | 3.3297 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-21 | Eingeleitet | Canaccord Genuity | Hold |
| 2026-03-10 | Eingeleitet | Jefferies | Hold |
| 2026-02-20 | Eingeleitet | Barclays | Equal Weight |
| 2026-01-20 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2026-01-07 | Fortgesetzt | UBS | Buy |
| 2025-12-05 | Hochstufung | Erste Group | Hold → Buy |
| 2025-11-24 | Fortgesetzt | Truist | Hold |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-09-03 | Fortgesetzt | Raymond James | Mkt Perform |
| 2025-05-20 | Fortgesetzt | Guggenheim | Neutral |
| 2025-04-22 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2024-12-10 | Fortgesetzt | BofA Securities | Underperform |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-14 | Eingeleitet | Citigroup | Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Outperform |
| 2024-10-14 | Herabstufung | Truist | Buy → Hold |
| 2024-09-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Fortgesetzt | Raymond James | Mkt Perform |
| 2024-02-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Hold |
| 2023-11-02 | Hochstufung | Truist | Hold → Buy |
| 2023-10-20 | Fortgesetzt | JP Morgan | Neutral |
| 2023-10-17 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Fortgesetzt | BofA Securities | Neutral |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-04-24 | Bestätigt | Oppenheimer | Outperform |
| 2023-03-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Bestätigt | Truist | Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Underperform |
| 2022-10-31 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-02-09 | Bestätigt | Barclays | Equal Weight |
| 2022-02-09 | Bestätigt | Jefferies | Buy |
| 2022-02-09 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-09 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-12-09 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2021-12-06 | Eingeleitet | Goldman | Buy |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-09-23 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Eingeleitet | Daiwa Securities | Buy |
| 2020-10-28 | Eingeleitet | UBS | Neutral |
| 2020-10-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Hochstufung | Truist | Hold → Buy |
| 2020-10-09 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Herabstufung | Truist | Buy → Hold |
| 2020-10-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Fortgesetzt | Guggenheim | Neutral |
| 2020-03-31 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-03-30 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Eingeleitet | Barclays | Equal Weight |
| 2020-01-31 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-17 | Fortgesetzt | Morgan Stanley | Overweight |
| 2019-11-12 | Eingeleitet | SunTrust | Buy |
| 2019-11-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-19 | Herabstufung | Mizuho | Buy → Neutral |
| 2019-05-23 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Amgen Inc Aktie (AMGN) Neueste Nachrichten
Amgen's Growth Engine Is Just Getting Started (NASDAQ:AMGN) - Seeking Alpha
AMGN Stock Down 13% in 3 Months: Buy the Dip or Book Profits? - TradingView
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Assessing Amgen (AMGN) Valuation After Japan Safety Concerns Over Rare Disease Drug - simplywall.st
Fisher Asset Management LLC Purchases 118,273 Shares of Amgen Inc. $AMGN - MarketBeat
My Personal Plan to Turn Market Chaos Into 300%+ Growth - Investing.com
Allstate Corp Has $13.13 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen stock (US0311621009): CFO retirement and earnings strength keep focus on guidance - AD HOC NEWS
Mita Ganatra Joins Amgen India as Executive Director, Finance - hrtoday.in
Amgen (AMGN) Announces Retirement of CFO Peter Griffith - Insider Monkey
Wealthquest Corp Acquires Shares of 3,374 Amgen Inc. $AMGN - MarketBeat
Legal & General Group Plc Boosts Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Bought by New Age Alpha Advisors LLC - MarketBeat
Simplify Asset Management Inc. Makes New Investment in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. (AMGN) Stock Analysis: Strong ROE and Promising Outlook in the Healthcare Sector - DirectorsTalk Interviews
Amgen Inc. $AMGN Shares Sold by Swedbank AB - MarketBeat
Amgen Inc. $AMGN is Smead Capital Management Inc.'s 5th Largest Position - MarketBeat
Amgen stock (US0311621009): Shares edge lower after early-February trade update - AD HOC NEWS
Amgen stock (US0311621009): earnings beat and leadership change put biotech giant in focus - AD HOC NEWS
Does Amgen’s CFO Transition and Board Structure Shape a New Governance Story for AMGN? - simplywall.st
Amgen Inc. (AMGN) is attracting investor attention: Here is what you should know - MSN
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It - MSN
Legato Capital Management LLC Acquires Shares of 8,328 Amgen Inc. $AMGN - MarketBeat
Axxcess Wealth Management LLC Raises Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Americana Partners LLC - MarketBeat
Amgen Inc. stock (US0311621009): weight-loss data and obesity ambitions move into focus - AD HOC NEWS
Amgen (NASDAQ:AMGN) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
Amgen Inc. (NASDAQ: AMGN) Stock Trades Near $330 as Japan Drug Safety Crisis Raises Concerns - foreignpolicyjournal.com
Amgen Inc. stock (US0311621009): obesity data, Horizon deal and pipeline put focus back on the biote - AD HOC NEWS
Keudell Morrison Wealth Management Makes New Investment in Amgen Inc. $AMGN - MarketBeat
Rx Rundown: Parabilis Medicines, Boston Scientific, Amgen and more - Medical Marketing and Media
Global Retirement Partners LLC Purchases 5,691 Shares of Amgen Inc. $AMGN - MarketBeat
AMGN Stock Chart | AMGEN INC (NASDAQ:AMGN) - ChartMill
A Look At Amgen (AMGN) Valuation As Tavneos Safety Concerns And Withdrawal Requests Escalate - Yahoo Finance
Amgen Inc. Stock 12‑Month Price Target Cut to $352.32, Implies 4% Upside - TradingView
Amgen stock (US0311621009): Q1 revenue tops estimates, CFO change keeps debt in focus - AD HOC NEWS
Amgen (AMGN) director Amy E. Miles awarded 665 RSUs, now holds 5,640 shares - Stock Titan
Amgen (AMGN) director Ellen Kullman receives 665-share RSU equity grant - Stock Titan
Amgen (NASDAQ: AMGN) director granted 665 RSUs in stock award - Stock Titan
Amgen (NASDAQ: AMGN) director granted 665-share equity award, now holds 18,284 - Stock Titan
Amgen Shareholders Reaffirm Board, Pay and Auditors - The Globe and Mail
Amgen (AMGN) director Omar Ishrak receives 665-share stock grant in Form 4 - Stock Titan
Amgen (AMGN) director Charles Holley receives 665-share RSU grant and reports 12.8K direct holdings - Stock Titan
Amgen (AMGN) director Garland receives 665 RSUs that vest immediately - Stock Titan
Amgen (AMGN) director receives 665 RSUs in immediate stock grant - Stock Titan
Amgen (NASDAQ: AMGN) director Brian Druker receives 665-share RSU grant - Stock Titan
Amgen (AMGN) director Michael V. Drake receives 665-share RSU award - Stock Titan
Amgen (AMGN) director receives 665-share RSU stock grant award - Stock Titan
Amgen’s ‘boomerang’ CFO reaps $12.5M in cash, retention bonuses - CFO Dive
Amgen Wants To Preserve Right To Seek Double Tax Relief - Law360
Amgen CFO Change Puts Focus On Debt, Growth And Capital Discipline - simplywall.st
Finanzdaten der Amgen Inc-Aktie (AMGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.05%
0.98%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):